Utah Medical Products, Inc. (UTMD)
69.16
-1.94
(-2.73%)
USD |
NASDAQ |
Sep 08, 16:00
67.99
-1.17
(-1.69%)
Pre-Market: 20:00
Utah Medical Products Total Assets (Quarterly) : 124.57M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 124.57M |
| March 31, 2026 | 124.38M |
| December 31, 2025 | 122.54M |
| September 30, 2025 | 121.98M |
| June 30, 2025 | 120.80M |
| March 31, 2025 | 122.52M |
| December 31, 2024 | 122.54M |
| September 30, 2024 | 129.69M |
| June 30, 2024 | 130.03M |
| March 31, 2024 | 135.44M |
| December 31, 2023 | 135.46M |
| September 30, 2023 | 131.24M |
| June 30, 2023 | 130.48M |
| March 31, 2023 | 127.77M |
| December 31, 2022 | 123.87M |
| September 30, 2022 | 118.41M |
| June 30, 2022 | 116.15M |
| March 31, 2022 | 119.80M |
| December 31, 2021 | 115.64M |
| September 30, 2021 | 119.75M |
| June 30, 2021 | 116.79M |
| March 31, 2021 | 114.39M |
| December 31, 2020 | 111.74M |
| September 30, 2020 | 107.07M |
| June 30, 2020 | 103.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 103.19M |
| December 31, 2019 | 109.79M |
| September 30, 2019 | 104.09M |
| June 30, 2019 | 103.36M |
| March 31, 2019 | 105.05M |
| December 31, 2018 | 99.77M |
| September 30, 2018 | 99.15M |
| June 30, 2018 | 97.04M |
| March 31, 2018 | 97.19M |
| December 31, 2017 | 92.74M |
| September 30, 2017 | 90.68M |
| June 30, 2017 | 85.94M |
| March 31, 2017 | 82.17M |
| December 31, 2016 | 76.58M |
| September 30, 2016 | 82.82M |
| June 30, 2016 | 81.04M |
| March 31, 2016 | 83.21M |
| December 31, 2015 | 79.18M |
| September 30, 2015 | 80.16M |
| June 30, 2015 | 79.93M |
| March 31, 2015 | 75.38M |
| December 31, 2014 | 81.08M |
| September 30, 2014 | 82.28M |
| June 30, 2014 | 84.29M |
| March 31, 2014 | 82.89M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Abbott Laboratories | 109.22B |
| AngioDynamics, Inc. | 267.16M |
| Alphatec Holdings, Inc. | 791.03M |
| AtriCure, Inc. | 676.64M |
| Baxter International, Inc. | 19.79B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.539M |
| Shareholders Equity (Quarterly) | 122.03M |
| Debt to Equity Ratio | 0.0016 |
| Current Ratio | 48.62 |
| Net Debt Paydown Yield | 0.01% |